Fig. 5
From: Clustering of HR + /HER2− breast cancer in an Asian cohort is driven by immune phenotypes
Prognostic analyses between different clusters a Overall survival by stage, adjusted for grade and clinical subtypes. b Overall survival by grade, adjusted for stage and clinical subtypes. c Overall survival by clinical subtypes, adjusted for stage and grade. d Overall survival by MyBrCa clusters, adjusted for stage and grade. In the right panel, small clusters with n < 20 were removed. e Overall survival by immune group, adjusted for stage and grade. f Overall survival by MyBrCa clusters adjusted for stage and grade, showing only clusters in Group 1 or Group 2. Adjustments were made using a Cox proportional hazard model. Sample sizes are reported in brackets. For d and f, Cox proportional hazard ratio p-values between the group with the best survival and the group with poorest survival are reported. For d, the p-value between Clusters 1 and 2 was reported. For f, the p-value between Cluster 7 and Cluster 5 was reported